Phase II trial of continuous low-dose temozolomide for patients with recurrent malignant glioma-Reference-Cited by-同舟云学术

Phase II trial of continuous low-dose temozolomide for patients with recurrent malignant glioma

Published:2012-12-14 Issue:2 Volume:15 Page:242-250
ISSN:1523-5866
Container-title:Neuro-Oncology
language:en
Short-container-title:

Author:

Omuro Antonio,Chan Timothy A.,Abrey Lauren E.,Khasraw Mustafa,Reiner Anne S.,Kaley Thomas J.,DeAngelis Lisa M.,Lassman Andrew B.,Nolan Craig P.,Gavrilovic Igor T.,Hormigo Adilia,Salvant Cynthia,Heguy Adriana,Kaufman Andrew,Huse Jason T.,Panageas Katherine S.,Hottinger Andreas F.,Mellinghoff Ingo

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,Clinical Neurology,Oncology

Link

http://academic.oup.com/neuro-oncology/article-pdf/15/2/242/16855503/nos295.pdf

Reference49 articles.

1. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma;Stupp;N Engl J Med,2005

2. Neurooncology clinical trial design for targeted therapies: lessons learned from the North American Brain Tumor Consortium;Chang;Neuro Oncol,2008

3. A phase II study of temozolomide vs. procarbazine in patients with glioblastoma multiforme at first relapse;Yung;Br J Cancer,2000

4. Outcomes and prognostic factors in recurrent glioma patients enrolled onto phase II clinical trials;Wong;J Clin Oncol,1999

5. Progression-free survival: an important end point in evaluating therapy for recurrent high-grade gliomas;Lamborn;Neuro Oncol,2008

Cited by 85 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current chemotherapy strategies for adults with IDH-wildtype glioblastoma;Frontiers in Oncology;2024-07-19

2. Assessment of Gamma Knife Stereotactic Radiosurgery as an Adjuvant Therapy in First-Line Management of Newly Diagnosed Glioblastoma: Insights from Ten Years at a Neuroscience Center;International Journal of Translational Medicine;2024-05-27

3. Effect of low-dose bevacizumab on health-related quality of life in patients with recurrent high-grade glioma: A retrospective clinical study;Journal of Clinical Neuroscience;2024-02

4. Metronomic chemotherapy as a potential partner of immune checkpoint inhibitors for metastatic colorectal cancer treatment;Cancer Letters;2023-07

5. Metronomic Temozolomide in Heavily Pretreated Patients With Recurrent Isocitrate Dehydrogenase Wild-type Glioblastoma: A Large Real-Life Mono-Institutional Study;Clinical Oncology;2023-05